Limits...
Diffusion of anti-VEGF injections in the Portuguese National Health System.

Marques AP, Macedo AF, Perelman J, Aguiar P, Rocha-Sousa A, Santana R - BMJ Open (2015)

Bottom Line: The availability of an ophthalmology department in the county increased the rates of hospital episodes by 243%, and a 100-persons greater density per km(2) raised the rates by 11%.Our study shows a large but unequal diffusion of anti-VEGF treatments despite the universal coverage and very low copayments.The technological innovation in ophthalmology may thus produce unexpected inequalities related to financial constraints unless the implementation of innovative techniques is planned and regulated.

View Article: PubMed Central - PubMed

Affiliation: Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal.

No MeSH data available.


Related in: MedlinePlus

Annual number of hospital episodes of antivascular endothelial growth factor (anti-VEGF) treatments and annual number of treated patients from 2002 to 2012.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4663428&req=5

BMJOPEN2015009006F1: Annual number of hospital episodes of antivascular endothelial growth factor (anti-VEGF) treatments and annual number of treated patients from 2002 to 2012.

Mentions: The final sample included 98 408 hospital episodes. Figure 1 shows that the total number of episodes increased from 1815 in 2002 to 25 106 in 2012. This corresponds to a mean annual increase of 32%.


Diffusion of anti-VEGF injections in the Portuguese National Health System.

Marques AP, Macedo AF, Perelman J, Aguiar P, Rocha-Sousa A, Santana R - BMJ Open (2015)

Annual number of hospital episodes of antivascular endothelial growth factor (anti-VEGF) treatments and annual number of treated patients from 2002 to 2012.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4663428&req=5

BMJOPEN2015009006F1: Annual number of hospital episodes of antivascular endothelial growth factor (anti-VEGF) treatments and annual number of treated patients from 2002 to 2012.
Mentions: The final sample included 98 408 hospital episodes. Figure 1 shows that the total number of episodes increased from 1815 in 2002 to 25 106 in 2012. This corresponds to a mean annual increase of 32%.

Bottom Line: The availability of an ophthalmology department in the county increased the rates of hospital episodes by 243%, and a 100-persons greater density per km(2) raised the rates by 11%.Our study shows a large but unequal diffusion of anti-VEGF treatments despite the universal coverage and very low copayments.The technological innovation in ophthalmology may thus produce unexpected inequalities related to financial constraints unless the implementation of innovative techniques is planned and regulated.

View Article: PubMed Central - PubMed

Affiliation: Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal.

No MeSH data available.


Related in: MedlinePlus